TSS:Hg 100399.1

Basic information about the TSS

---

TSS ID: hg_100399.1 Species: human Chr: chr9		Start: 32573173 End: 32573189 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000366466.5 NM_001199987 Distance: 0 GeneID: 4712 HGNC/MGI_ID: HGNC:7701 UniProt_ID: A0A087WZX2

Gene_name: NADH:ubiquinone oxidoreductase subunit B6 Gene_symbol: NDUFB6 Gene_synonyms: B17 CI Gene_source: HGNC:7701

TATA-Box annotation

---

Distance to TSS:	3
Nearest PromoterID:	NM_001199987
Entrez ID:	4712
Nearest Unigene:	Hs.493668
Nearest Refseq:	NM_002493
Nearest Ensembl:	ENSG00000165264
Gene Name:	NADH:ubiquinone oxidoreductase subunit B6
Gene Alias:	B17|CI
Gene Description:	NADH:ubiquinone oxidoreductase subunit B6
Gene Type:	protein-coding
CpG%:	0.1
GC%:	0.597015
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NDUFB6 p3@NDUFB6 p4@NDUFB6
Sample		p1@NDUFB6	p3@NDUFB6	p4@NDUFB6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	35.26	11.69	10.71
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	47.34	14.36	11.33
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	43.79	16.98	11.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	39.71	15.39	8.32
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	42.74	14.62	11.70
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	38.37	12.99	10.66
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	43.79	18.08	12.42
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	46.51	16.96	8.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	43.81	13.89	8.55
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.23	8.69	5.22
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.55	10.91	4.45
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	10.98	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	37.24	7.90	7.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	34.43	8.27	6.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.06	9.66	6.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	33.20	4.78	6.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.45	5.68	5.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.42	6.75	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	42.65	5.86	5.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	50.70	9.33	7.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	41.57	8.42	6.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	44.88	8.80	12.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	35.03	5.69	5.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	38.83	7.28	4.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	44.37	8.77	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	49.38	8.55	10.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	45.06	9.89	12.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	46.68	8.25	9.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	51.53	8.72	8.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	42.35	7.24	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.47	6.28	7.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	43.96	7.03	8.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	46.22	9.71	8.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	63.50	10.56	13.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	46.93	10.28	6.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	39.09	6.90	6.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	49.66	8.79	8.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	45.13	5.04	7.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	65.91	9.45	11.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	60.02	10.80	11.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	39.29	7.53	6.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	49.63	11.42	10.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	43.44	7.17	8.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	48.43	7.34	7.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	53.81	10.44	9.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	64.44	11.17	9.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	40.06	6.00	6.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	81.67	11.03	9.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	43.09	9.81	6.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	40.84	10.31	6.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	45.50	11.89	9.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	47.37	10.67	10.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	27.98	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.94	8.52	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	33.14	5.30	8.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	74.67	17.62	21.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	87.72	14.24	16.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	22.69	8.75	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	25.05	5.14	5.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	63.81	12.89	13.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	27.50	4.23	5.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	22.43	3.36	7.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	62.10	16.72	16.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	45.53	10.19	16.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	22.09	6.17	5.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.52	5.32	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	7.90	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	27.30	2.44	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.28	4.96	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.99	0.94	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	41.40	9.60	5.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	20.73	4.64	3.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	23.85	5.20	4.28
Adipocyte - breast, donor1	11376-118A8	51.32	9.82	11.88
Adipocyte - breast, donor2	11327-117E4	37.54	11.39	8.82
Adipocyte - omental, donor1	11473-119C6	38.80	11.07	10.18
Adipocyte - omental, donor2	11474-119C7	61.29	9.72	13.45
Adipocyte - omental, donor3	11475-119C8	48.90	8.37	13.06
Adipocyte - perirenal, donor1	11476-119C9	61.89	8.93	12.12
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	7.70	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	52.84	6.77	9.03
Adipocyte - subcutaneous, donor3	11408-118E4	28.85	8.17	5.56
Adipocyte differentiation, day04, donor1	13019-139D4	39.70	9.58	7.82
Adipocyte differentiation, day04, donor2	13022-139D7	31.14	6.43	6.95
Adipocyte differentiation, day04, donor3	13025-139E1	40.70	8.36	6.97
Adipocyte differentiation, day04, donor4	13028-139E4	30.57	6.47	8.23
Adipocyte differentiation, day08, donor1	13020-139D5	50.51	23.49	9.65
Adipocyte differentiation, day08, donor2	13023-139D8	33.24	11.94	3.23
Adipocyte differentiation, day08, donor3	13026-139E2	35.72	12.26	4.80
Adipocyte differentiation, day08, donor4	13029-139E5	36.72	13.35	5.56
Adipocyte differentiation, day12, donor1	13021-139D6	59.89	20.79	12.48
Adipocyte differentiation, day12, donor2	13024-139D9	32.15	12.31	6.78
Adipocyte differentiation, day12, donor3	13027-139E3	36.00	17.34	7.20
Adipocyte differentiation, day12, donor4	13030-139E6	38.06	14.61	4.87
Alveolar Epithelial Cells, donor1	11510-119G7	59.45	13.26	8.62
Alveolar Epithelial Cells, donor2	11590-120G6	28.33	6.10	6.81
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	4.79	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	49.65	8.10	12.95
Amniotic Epithelial Cells, donor2	11613-122A2	35.14	6.69	15.06
Amniotic Epithelial Cells, donor3	11694-123A2	44.58	9.86	8.63
Anulus Pulposus Cell, donor1	11248-116E6	50.46	9.84	11.79
Anulus Pulposus Cell, donor2	11463-119B5	59.02	4.90	8.82
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	51.67	9.44	13.03
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	51.23	13.46	9.99
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	8.56	10.70
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	46.63	10.46	11.66
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	55.64	12.65	20.23
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	46.20	10.56	9.90
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	53.93	10.07	10.72
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	46.60	6.31	12.14
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	54.04	11.28	16.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	59.89	11.68	7.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	55.15	10.16	13.79
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	37.61	12.54	7.52
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	51.23	7.91	11.86
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	68.24	6.82	8.19
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	72.23	14.02	12.97
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	57.86	5.89	12.86
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	53.28	9.45	10.58
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	50.78	9.62	12.03
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	56.58	9.75	4.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	45.78	9.45	10.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	56.43	9.61	6.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	60.18	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	43.23	7.20	9.09
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	37.75	4.19	12.58
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	54.85	5.34	9.22
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	53.12	9.49	12.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	52.09	10.90	12.11
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	47.31	17.10	16.53
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	52.59	8.34	8.34
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	50.59	10.84	9.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	53.49	9.38	9.85
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	46.62	7.40	11.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	47.80	7.85	9.99
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	43.87	12.28	16.38
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	49.68	9.63	10.84
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	46.33	11.88	11.88
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	52.89	8.14	10.17
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	56.54	10.70	11.21
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	48.92	10.80	10.80
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	46.17	12.08	7.77
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	60.97	10.80	9.31
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	46.40	15.37	13.05
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	42.51	8.50	13.23
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	48.48	10.17	9.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	13.90	13.90
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	88.73	8.45	8.45
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	49.96	7.50	9.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	45.12	11.43	12.03
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	62.69	10.21	11.66
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	57.47	6.44	7.82
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	5.10	15.30
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	93.05	21.36	18.81
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	60.69	11.15	11.35
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	42.84	11.63	14.08
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	56.41	10.04	10.04
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	51.22	11.09	8.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	35.09	18.31	10.68
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	50.40	7.20	9.42
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	51.11	7.15	11.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	42.52	8.72	11.27
Astrocyte - cerebellum, donor1	11500-119F6	88.67	16.58	17.56
Astrocyte - cerebellum, donor2	11580-120F5	65.73	8.73	20.20
Astrocyte - cerebellum, donor3	11661-122F5	43.63	5.87	14.26
Astrocyte - cerebral cortex, donor1	11235-116D2	62.40	12.55	13.94
Astrocyte - cerebral cortex, donor2	11316-117D2	61.80	14.72	13.59
Astrocyte - cerebral cortex, donor3	11392-118C6	64.88	12.68	13.72
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	43.35	12.04	7.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	47.98	13.41	6.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	41.42	15.25	6.71
Basophils, donor1	12241-129G9	18.57	5.75	1.83
Basophils, donor2	12242-129H1	21.65	8.30	2.89
Basophils, donor3	12243-129H2	14.41	2.79	1.76
Bronchial Epithelial Cell, donor1	11511-119G8	25.23	4.53	2.59
Bronchial Epithelial Cell, donor2	11591-120G7	8.69	0.46	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	46.45	4.39	11.30
Bronchial Epithelial Cell, donor5	11457-119A8	28.07	4.99	6.03
Bronchial Epithelial Cell, donor6	11461-119B3	9.44	1.61	3.45
Bronchial Epithelial Cell, donor7	11769-123I5	29.15	5.58	3.78
Burkitt's lymphoma cell line:DAUDI	10422-106C8	17.11	13.09	2.58
Burkitt's lymphoma cell line:RAJI	10476-106I8	19.10	19.33	4.19
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	87.30	44.45	17.59
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	41.37	31.03
CD14+ Monocytes, donor1	11224-116B9	14.65	1.13	2.25
CD14+ Monocytes, donor2	11305-117B9	6.12	1.11	1.11
CD14+ Monocytes, donor3	11381-118B4	7.68	3.73	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	45.57	9.91	4.25
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	44.35	8.72	5.31
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	40.76	8.88	5.59
CD14+ monocytes - mock treated, donor1	11863-125A9	6.07	1.01	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	3.92	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	6.40	1.42	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.85	2.01	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.97	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.46	1.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.66	1.96	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.34	1.25	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	15.23	4.13	2.61
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.79	3.28	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.28	1.06	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	8.87	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.02	2.08	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.39	0.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.91	4.79	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.18	0.69	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.33	2.71	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	4.80	2.62	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.65	2.15	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.46	1.74	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	8.42	2.95	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	6.98	2.39	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	1.76	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.58	3.07	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.10	1.39	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.81	2.97	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.01	4.31	2.59
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.32	2.46	2.46
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	5.56	1.85	2.32
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	13.92	3.48	2.55
CD14+CD16+ Monocytes, donor1	11789-124B7	44.46	11.55	8.06
CD14+CD16+ Monocytes, donor2	11801-124D1	37.19	8.32	5.54
CD14+CD16+ Monocytes, donor3	11912-125G4	51.12	10.40	7.15
CD14+CD16- Monocytes, donor1	11788-124B6	35.04	9.50	3.89
CD14+CD16- Monocytes, donor2	11799-124C8	31.61	7.34	5.76
CD14+CD16- Monocytes, donor3	11910-125G2	26.76	9.59	3.34
CD14-CD16+ Monocytes, donor1	11790-124B8	72.72	18.12	5.10
CD14-CD16+ Monocytes, donor2	11800-124C9	43.25	12.30	6.15
CD14-CD16+ Monocytes, donor3	11911-125G3	53.06	16.21	7.37
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	63.00	26.42	10.16
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	48.81	15.59	6.10
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	50.74	20.71	8.28
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	67.16	14.39	9.06
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	56.29	17.69	11.26
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	68.09	19.65	7.72
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	58.83	25.10	7.84
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	67.23	17.14	7.91
CD19+ B Cells, donor1	11544-120B5	11.51	0.82	3.29
CD19+ B Cells, donor2	11624-122B4	8.71	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	11.11	3.03	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	131.32	43.64	14.55
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	159.40	51.53	18.78
CD34+ Progenitors, donor1	11545-120B6	36.15	14.06	5.02
CD34+ Progenitors, donor2	11625-122B5	24.72	7.30	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	83.79	22.55	15.03
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	121.31	42.84	21.65
CD4+ T Cells, donor1	11225-116C1	8.21	5.00	0.71
CD4+ T Cells, donor2	11306-117C1	10.41	6.12	0.61
CD4+ T Cells, donor3	11382-118B5	8.84	6.10	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	58.45	19.91	11.23
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	55.48	17.07	9.21
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	41.97	15.81	7.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	20.86	13.27	6.16
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	30.90	7.73	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	13.18	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	28.76	10.12	4.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	37.28	13.22	5.08
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	33.21	11.28	5.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	43.04	9.41	6.28
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	41.58	15.72	5.59
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	47.96	15.84	8.80
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.89	11.81	6.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	32.83	12.67	6.65
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	41.10	11.69	9.02
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	17.40	5.71	3.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	23.58	11.25	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	19.73	16.14	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	44.50	17.06	5.01
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	45.49	14.95	5.42
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	38.46	13.87	6.09
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	30.84	13.15	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	43.33	14.30	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	29.64	8.72	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	45.53	19.30	4.95
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	41.54	21.23	5.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	50.25	20.94	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	45.42	14.12	4.98
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	52.27	14.23	4.42
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	53.90	16.94	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	44.76	20.77	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	77.56	24.93	6.92
CD8+ T Cells, donor1	11226-116C2	7.20	5.24	1.31
CD8+ T Cells, donor2	11307-117C2	6.01	3.00	0.38
CD8+ T Cells, donor3	11383-118B6	8.84	4.80	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	25.23	8.72	8.95
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.73	9.11	6.71
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	18.06	7.11	4.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	24.92	10.21	8.41
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.36	6.00	6.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.69	8.87	8.41
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.33	9.56	10.86
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	19.21	8.42	7.90
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	30.96	11.49	11.02
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	30.19	16.91	8.45
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	31.37	11.62	9.01
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.11	14.12	12.52
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	9.63	7.00	2.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.47	8.65	3.19
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	10.44	5.22	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.13	8.64	7.20
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.70	7.77	6.91
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	22.16	7.78	6.84
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	24.08	11.73	15.53
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.68	8.61	9.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	21.48	12.50	5.45
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	20.27	9.56	8.03
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	28.38	13.01	8.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.96	7.56	13.62
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.89	14.45	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.98	15.39	6.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	18.03	9.02	14.02
Cardiac Myocyte, donor1	11525-119I4	34.73	5.48	20.11
Cardiac Myocyte, donor2	11605-120I3	67.69	11.86	18.28
Cardiac Myocyte, donor3	11686-122I3	58.19	9.47	12.10
Chondrocyte - de diff, donor1	11261-116G1	57.20	10.40	10.05
Chondrocyte - de diff, donor2	11338-117F6	40.51	5.33	6.04
Chondrocyte - de diff, donor3	11410-118E6	44.03	7.62	7.85
Chondrocyte - re diff, donor2	11339-117F7	46.55	7.16	13.43
Chondrocyte - re diff, donor3	11411-118E7	45.29	9.30	5.26
Ciliary Epithelial Cells, donor1	11242-116D9	69.77	12.85	18.48
Ciliary Epithelial Cells, donor2	11323-117D9	54.30	10.26	18.60
Ciliary Epithelial Cells, donor3	11399-118D4	60.71	9.38	12.66
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	58.87	14.49	10.45
Corneal Epithelial Cells, donor1	11526-119I5	40.18	6.59	9.66
Corneal Epithelial Cells, donor2	11606-120I4	36.40	4.55	6.83
Corneal Epithelial Cells, donor3	11687-122I4	54.45	12.53	13.04
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	49.03	21.63	7.26
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	60.24	22.08	11.04
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	31.06	27.61
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	43.41	19.44	6.16
Dendritic Cells - plasmacytoid, donor1	11228-116C4	40.31	9.57	8.20
Dendritic Cells - plasmacytoid, donor2	11309-117C4	52.23	13.71	14.36
Dendritic Cells - plasmacytoid, donor3	11385-118B8	65.33	15.97	14.03
Endothelial Cells - Aortic, donor0	11207-116A1	17.18	4.84	4.00
Endothelial Cells - Aortic, donor1	11263-116G3	25.23	5.87	6.45
Endothelial Cells - Aortic, donor2	11340-117F8	29.41	4.81	7.07
Endothelial Cells - Aortic, donor3	11412-118E8	21.23	3.93	5.11
Endothelial Cells - Artery, donor1	11264-116G4	18.91	3.49	4.36
Endothelial Cells - Artery, donor2	11341-117F9	31.29	4.24	3.53
Endothelial Cells - Artery, donor3	11413-118E9	25.95	5.08	4.73
Endothelial Cells - Lymphatic, donor1	11236-116D3	37.24	5.98	6.43
Endothelial Cells - Lymphatic, donor2	11317-117D3	38.34	10.35	6.69
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.65	2.82	4.51
Endothelial Cells - Microvascular, donor1	11265-116G5	35.95	7.13	9.51
Endothelial Cells - Microvascular, donor2	11342-117G1	31.76	4.17	3.64
Endothelial Cells - Microvascular, donor3	11414-118F1	18.86	3.97	5.10
Endothelial Cells - Thoracic, donor1	11266-116G6	58.42	8.00	9.60
Endothelial Cells - Thoracic, donor2	11343-117G2	19.39	5.24	7.34
Endothelial Cells - Umbilical vein, donor1	11243-116E1	51.19	11.55	13.17
Endothelial Cells - Umbilical vein, donor2	11324-117E1	44.97	9.34	6.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	42.87	9.53	9.65
Endothelial Cells - Vein, donor1	11267-116G7	40.95	7.96	1.14
Endothelial Cells - Vein, donor2	11344-117G3	20.96	2.79	4.89
Endothelial Cells - Vein, donor3	11416-118F3	35.48	8.95	7.22
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00
Eosinophils, donor2	12245-129H4	87.46	66.01	9.90
Eosinophils, donor3	12246-129H5	82.04	60.64	10.70
Esophageal Epithelial Cells, donor1	11507-119G4	33.23	7.57	5.62
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	41.46	10.67	8.62
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	34.16	7.12	7.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	47.89	13.00	11.38
Fibroblast - Aortic Adventitial, donor1	11245-116E3	49.97	10.79	12.86
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	40.12	5.73	10.10
Fibroblast - Aortic Adventitial, donor2	11326-117E3	32.80	7.17	7.91
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	27.93	7.11	5.80
Fibroblast - Aortic Adventitial, donor3	11401-118D6	49.17	16.28	5.98
Fibroblast - Cardiac, donor1	11268-116G8	42.64	5.90	12.70
Fibroblast - Cardiac, donor2	11345-117G4	31.83	4.55	5.31
Fibroblast - Cardiac, donor3	11417-118F4	29.34	4.26	7.41
Fibroblast - Cardiac, donor4	11452-119A3	42.44	8.49	7.27
Fibroblast - Cardiac, donor5	11456-119A7	51.78	9.14	10.66
Fibroblast - Cardiac, donor6	11460-119B2	64.58	8.34	11.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	50.92	6.43	11.79
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.53	4.31	7.33
Fibroblast - Choroid Plexus, donor3	11653-122E6	58.59	10.25	11.72
Fibroblast - Conjunctival, donor1	11531-120A1	51.20	11.07	13.15
Fibroblast - Conjunctival, donor3	11692-122I9	33.24	5.26	7.63
Fibroblast - Dermal, donor1	11269-116G9	46.02	9.16	8.69
Fibroblast - Dermal, donor2	11346-117G5	34.43	5.19	10.38
Fibroblast - Dermal, donor3	11418-118F5	53.31	8.82	13.54
Fibroblast - Dermal, donor4	11450-119A1	59.24	9.50	14.47
Fibroblast - Dermal, donor5	11454-119A5	73.62	12.91	13.08
Fibroblast - Dermal, donor6	11458-119A9	80.40	12.18	14.29
Fibroblast - Gingival, donor1	11237-116D4	41.02	9.16	10.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	50.57	7.86	14.15
Fibroblast - Gingival, donor2	11318-117D4	77.36	14.63	17.92
Fibroblast - Gingival, donor3	11394-118C8	23.20	3.58	6.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	3.12	9.35
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	28.54	5.81	6.52
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	70.93	15.43	14.19
Fibroblast - Gingival, donor6 (control)	11922-125H5	60.45	11.09	16.09
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	11.65	1.76	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	72.98	11.85	16.96
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	61.77	11.86	19.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	62.53	14.48	18.32
Fibroblast - Gingival, donor9 (control)	11927-125I1	35.95	6.90	6.46
Fibroblast - Lung, donor1	11270-116H1	29.91	2.72	2.72
Fibroblast - Lung, donor2	11347-117G6	47.75	0.00	5.97
Fibroblast - Lung, donor3	11419-118F6	39.67	9.92	6.54
Fibroblast - Lymphatic, donor1	11506-119G3	70.81	5.00	12.50
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	0.00	5.59
Fibroblast - Lymphatic, donor3	11667-122G2	14.55	2.80	5.60
Fibroblast - Mammary, donor1	11540-120B1	53.99	10.96	13.80
Fibroblast - Mammary, donor2	11620-122A9	51.92	11.98	11.98
Fibroblast - Mammary, donor3	11701-123A9	29.78	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	78.56	18.04	18.04
Fibroblast - Periodontal Ligament, donor2	11319-117D5	50.81	12.89	13.65
Fibroblast - Periodontal Ligament, donor3	11395-118C9	39.78	7.04	4.59
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	46.94	5.72	12.21
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	63.18	11.88	13.23
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.49	7.65	7.07
Fibroblast - Pulmonary Artery, donor1	11250-116E8	78.48	18.24	16.80
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	52.02	9.96	9.35
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	52.12	9.35	11.36
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	58.91	10.67	10.67
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	32.55	6.35	5.75
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	39.79	5.51	8.35
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	52.82	9.66	9.26
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	38.81	5.42	7.22
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	55.38	7.45	11.98
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	37.71	4.56	7.85
Fibroblast - skin normal, donor1	11553-120C5	46.27	7.88	11.65
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	38.70	6.62	8.02
Fibroblast - skin normal, donor2	11561-120D4	61.48	10.55	13.56
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	46.85	5.14	7.25
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	40.43	7.46	10.27
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	57.78	6.84	8.89
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	32.84	5.91	7.88
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	67.22	12.25	13.63
Fibroblast - skin walker warburg, donor1	11554-120C6	77.59	10.12	15.52
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	66.02	13.64	22.90
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	22.16	88.64
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	36.60	4.36	8.72
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	50.45	11.96	8.67
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	50.23	9.63	6.51
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	43.18	10.99	5.62
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	60.48	34.45	8.42
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	65.72	40.84	15.95
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	140.64	67.61	20.25
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	68.11	21.51	10.75
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	41.33	15.98	11.19
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	86.78	37.64	12.68
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	61.85	16.65	8.72
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	44.36	13.70	8.15
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	103.92	45.55	16.36
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	48.19	13.14	6.92
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	42.85	15.52	9.36
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	45.13	13.43	4.30
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	54.27	11.77	8.92
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	53.29	13.43	9.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	46.96	13.21	9.15
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	44.04	8.21	6.39
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	47.83	9.59	7.72
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	40.00	8.74	5.46
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	52.89	12.11	13.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	58.02	12.88	9.86
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	38.43	11.84	6.26
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	44.36	12.30	9.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	64.80	10.35	10.52
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.99	11.88	9.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	41.41	8.74	6.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.91	8.54	7.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	56.88	10.40	11.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.33	14.06	8.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	65.13	13.27	11.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	51.16	15.27	9.90
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	52.00	8.99	7.49
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	54.03	9.51	8.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	36.81	9.04	7.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	54.98	9.22	9.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	47.33	9.73	10.37
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	42.33	8.98	7.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	49.75	9.00	6.63
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	48.88	9.65	8.38
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	48.05	8.51	9.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	59.27	12.23	9.83
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	52.91	10.10	9.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	54.71	8.98	8.42
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	51.20	9.72	11.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	58.56	13.10	10.96
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	56.61	10.25	11.32
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	67.62	13.21	13.08
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	55.30	7.05	7.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.62	10.14	10.14
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	49.13	11.18	9.43
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	20.83	3.97	4.96
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	51.97	11.48	10.16
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	50.64	8.47	8.27
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	17.79	4.07	2.80
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	52.75	16.92	6.37
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	40.83	16.49	6.93
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	47.87	19.64	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	103.89	47.25	17.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	107.94	45.77	14.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	88.55	25.37	11.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	81.67	22.27	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	90.90	25.92	17.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	107.50	43.32	17.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	67.81	19.13	17.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	90.48	32.22	15.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	78.24	30.47	14.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	6.66	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	83.34	27.69	18.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	79.10	22.23	14.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	59.56	26.84	15.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	73.16	24.17	15.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	92.39	22.42	15.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	167.05	29.23	27.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	82.47	18.33	13.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	68.96	14.21	13.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	99.95	33.88	15.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	111.42	24.85	20.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	76.40	20.94	14.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	100.10	36.88	31.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	80.73	26.52	18.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	77.91	26.08	14.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	106.35	36.79	27.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	82.45	15.41	19.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	80.11	16.77	15.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	69.57	7.45	24.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	75.02	19.35	13.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	89.32	18.71	10.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	95.63	16.79	18.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	82.16	20.34	13.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	100.15	13.81	26.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	120.40	25.97	27.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	98.02	22.75	18.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	84.70	17.12	14.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	74.60	16.95	14.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	104.46	18.50	22.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	88.80	17.47	25.72
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	22.83	4.57	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	24.95	2.08	4.16
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	34.86	3.37	9.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	27.28	4.76	4.44
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	38.43	7.52	7.10
Hep-2 cells mock treated, biol_rep1	11898-125E8	69.28	16.71	15.67
Hep-2 cells mock treated, biol_rep2	11899-125E9	79.51	17.56	14.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	79.85	13.20	16.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	79.14	19.13	17.05
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	75.00	15.69	15.69
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	67.17	14.85	13.56
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	78.71	16.69	15.82
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	72.57	18.36	17.33
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	74.97	13.78	16.66
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	45.33	6.16	8.95
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	29.00	8.22	10.39
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	63.45	2.64	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	67.37	9.52	16.93
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	46.50	6.54	15.98
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	63.29	13.64	17.31
Hepatocyte, donor1	11523-119I2	69.00	21.79	16.95
Hepatocyte, donor2	11603-120I1	47.40	9.70	8.62
Hepatocyte, donor3	11684-122I1	58.29	7.98	9.82
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	79.63	30.02	19.58
Intestinal epithelial cells (polarized), donor1	11246-116E4	59.95	16.95	8.39
Iris Pigment Epithelial Cells, donor1	11530-119I9	57.63	8.78	9.47
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	4.15	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	7.51	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	7.69	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	9.14	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	4.87	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	11.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	7.26	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	18.53	5.29	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	8.87	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	26.45	7.56	5.67
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	24.75	3.09	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	19.38	7.75	5.17
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	26.89	8.15	7.33
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.63	5.04	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	3.21	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	3.69	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	32.57	8.97	4.25
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	23.58	3.63	7.26
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	3.23	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	17.79	7.62	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.12	6.38	5.10
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	3.65	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	16.42	6.43	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	32.41	7.41	4.32
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	3.51	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	3.14	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	18.08	5.56	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	6.64	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	6.10	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	3.48	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	2.13	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	5.54	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	13.81	4.60	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	6.05	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	16.56	2.61	2.77
Keratinocyte - epidermal, donor2	11349-117G8	14.06	0.59	6.44
Keratinocyte - epidermal, donor3	11421-118F8	56.70	11.64	9.65
Keratinocyte - oral, donor1	11251-116E9	47.90	9.31	8.51
Keratocytes, donor1	11527-119I6	73.24	16.85	19.94
Keratocytes, donor2	11607-120I5	67.96	8.20	8.20
Keratocytes, donor3	11688-122I5	41.30	6.72	9.48
Krukenberg tumor cell line:HSKTC	10687-109F3	118.69	10.99	26.37
Lens Epithelial Cells, donor1	11529-119I8	48.54	8.63	10.79
Lens Epithelial Cells, donor2	11609-120I7	58.36	6.57	9.34
Lens Epithelial Cells, donor3	11690-122I7	45.11	6.36	11.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	46.84	9.01	8.77
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	36.56	9.21	9.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	43.76	8.34	9.92
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	47.32	11.83	4.84
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	35.61	5.04	7.25
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	36.66	6.47	8.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	47.61	4.10	9.44
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	37.67	6.32	8.34
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.67	6.90	7.04
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	30.06	7.12	8.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	41.30	7.17	9.31
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	29.62	5.18	6.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	47.73	5.92	6.62
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.59	5.01	5.96
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	32.55	6.04	8.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	42.19	9.85	5.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	31.49	6.23	6.86
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.53	6.95	6.04
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	45.09	7.57	9.54
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	29.87	3.81	6.74
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	26.14	3.73	7.22
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	47.04	5.33	10.67
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	40.93	5.39	7.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	35.73	6.66	9.54
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	46.14	9.33	9.85
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.67	5.86	8.17
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	32.63	7.22	6.77
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	40.58	11.01	7.57
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	37.44	8.47	7.71
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.73	6.36	6.36
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	31.98	7.75	5.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	33.41	8.60	8.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	32.09	7.06	7.19
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	37.76	7.77	6.66
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	36.07	4.94	7.91
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	28.19	4.67	6.19
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	36.99	3.86	6.75
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	36.52	7.30	9.13
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.65	8.12	6.30
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	36.62	7.47	8.18
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	32.48	8.24	6.30
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	25.36	4.98	4.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	49.78	5.73	7.88
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	35.93	4.25	5.88
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	26.37	4.71	5.89
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	39.48	5.45	7.67
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.77	3.84	5.89
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.75	3.28	6.56
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	9.06	13.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	20.71	4.60	8.44
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.75	6.68	5.94
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	22.00	4.65	10.16
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.80	4.22	5.63
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	23.35	6.54	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.61	7.21	8.24
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	29.74	3.57	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.69	6.11	8.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.03	5.23	10.47
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.21	5.85	8.10
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	23.57	5.69	9.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.08	6.16	6.16
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	37.05	6.00	10.23
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	33.98	8.00	8.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.51	5.09	6.62
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	34.15	7.20	11.47
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	42.32	7.18	11.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	25.16	2.45	5.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	10.60	8.15
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	36.65	6.87	9.58
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	35.59	7.57	11.77
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	24.73	3.09	7.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	41.51	6.39	13.93
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	34.38	5.68	7.47
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	31.54	4.43	7.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	25.45	4.95	4.24
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	30.24	7.74	5.90
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	4.61	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	27.25	4.22	8.06
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	29.44	5.66	6.79
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	26.25	0.82	9.85
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	28.47	7.23	7.68
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	28.01	5.75	6.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	31.37	2.99	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	27.13	4.83	7.06
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	34.89	4.31	11.63
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	28.26	3.43	12.84
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.99	6.33	7.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	27.75	2.41	6.03
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	23.46	1.42	4.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	25.44	2.06	7.56
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	21.47	2.68	3.76
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	26.93	1.35	5.39
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.34	5.93	8.15
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	41.87	8.14	19.77
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	23.27	5.29	7.40
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	26.81	3.60	4.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	3.63	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	25.30	12.26	8.43
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	25.16	3.95	9.87
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	1.88	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.63	3.52	10.06
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	15.32	3.15	8.11
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	1.72	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	21.82	6.68	10.24
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	20.33	2.74	8.60
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	29.03	3.96	5.28
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	33.21	5.71	11.94
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	18.38	4.81	7.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	26.84	2.80	8.39
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	29.15	8.39	5.74
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	27.77	5.40	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	26.33	4.56	6.58
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	19.22	6.73	7.21
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	27.83	5.57	11.13
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.66	3.04	9.72
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.75	4.84	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.94	6.46	9.12
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.30	4.13	9.30
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	32.05	3.63	8.47
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.77	4.12	9.51
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	28.79	3.73	8.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.14	4.60	5.75
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.17	6.69	9.26
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.71	4.24	12.73
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.56	3.97	7.38
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	23.30	3.33	7.49
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	20.36	3.92	5.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.65	3.76	5.85
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	21.84	4.18	6.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.76	4.68	6.02
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	25.66	6.95	9.62
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.82	3.64	7.68
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	3.67	8.26
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	21.34	2.67	7.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	32.48	4.56	6.84
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.07	2.30	16.87
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	27.36	4.92	8.21
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	21.38	4.45	9.80
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.92	4.16	11.70
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	31.83	4.64	5.97
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	53.10	10.94	5.70
Macrophage - monocyte derived, donor2	11313-117C8	99.83	47.90	13.21
Macrophage - monocyte derived, donor3	11389-118C3	50.99	22.02	8.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	83.37	17.52	15.40
Mallassez-derived cells, donor2	11929-125I3	53.24	6.65	12.99
Mallassez-derived cells, donor3	11930-125I4	65.88	14.73	13.20
Mammary Epithelial Cell, donor1	11273-116H4	39.56	11.26	9.57
Mammary Epithelial Cell, donor2	11350-117G9	48.07	14.19	7.82
Mammary Epithelial Cell, donor3	11422-118F9	28.19	4.74	3.49
Mast cell - stimulated, donor1	11487-119E2	21.02	9.49	5.42
Mast cell, donor1	11563-120D6	33.31	9.08	5.52
Mast cell, donor2	11565-120D8	22.59	4.75	4.46
Mast cell, donor3	11566-120D9	30.39	5.63	6.30
Mast cell, donor4	11567-120E1	23.40	4.43	2.66
Mast cell, expanded and stimulated, donor5	11940-126A5	56.67	14.19	11.09
Mast cell, expanded and stimulated, donor8	11942-126A7	28.60	11.67	6.42
Mast cell, expanded, donor5	11939-126A4	65.74	14.91	10.78
Mast cell, expanded, donor8	11941-126A6	36.65	11.38	3.51
Melanocyte - dark, donor1	11502-119F8	64.87	10.35	10.35
Melanocyte - dark, donor2	11582-120F7	67.83	10.38	18.69
Melanocyte - dark, donor3	11663-122F7	87.94	16.30	12.39
Melanocyte - light, donor1	11274-116H5	12.69	2.35	2.82
Melanocyte - light, donor2	11351-117H1	24.57	2.73	3.41
Melanocyte - light, donor3	11423-118G1	19.08	1.73	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	81.01	11.77	12.91
Melanocyte, donor2 (MC+2)	12739-135I3	71.27	10.49	15.60
Melanocyte, donor3 (MC+3)	12837-137B2	38.04	6.70	8.84
Meningeal Cells, donor1	11493-119E8	76.92	11.66	15.76
Meningeal Cells, donor2	11573-120E7	55.90	6.16	11.88
Meningeal Cells, donor3	11654-122E7	58.84	14.34	15.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	103.23	24.81	22.81
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	43.17	6.94	10.06
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	3.94	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	30.09	10.47	18.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	72.48	16.50	12.92
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	47.86	8.05	11.86
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	43.73	9.55	13.07
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	82.19	20.44	21.76
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	75.25	21.92	24.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	58.11	18.01	14.32
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	63.02	8.59	8.31
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	38.29	5.95	13.01
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	40.66	8.82	7.89
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	26.71	3.86	5.64
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	4.67	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	74.93	17.29	15.37
Mesenchymal stem cells - adipose, donor0	11217-116B2	81.52	18.08	17.01
Mesenchymal stem cells - hepatic, donor0	11218-116B3	44.72	8.13	9.38
Mesenchymal stem cells - umbilical, donor0	11214-116A8	95.07	26.85	23.22
Mesothelial Cells, donor1	11247-116E5	58.87	11.40	14.05
Mesothelial Cells, donor2	12156-128G5	72.57	15.01	18.02
Mesothelial Cells, donor3	11402-118D7	36.13	4.48	7.80
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	9.45	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	50.73	19.46	10.59
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	61.54	21.79	9.42
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	13.83	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	50.21	22.63	11.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.54	18.05	5.81
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	66.57	18.02	11.01
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.94	15.36	7.45
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.01	18.29	9.35
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	52.27	20.59	5.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	25.65	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	40.71	16.81	8.85
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	70.29	28.50	11.78
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	3.95	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	48.81	12.73	7.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	35.91	11.05	9.21
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.40	12.52	4.47
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	13.41	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	51.69	17.31	7.78
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	41.35	18.06	8.32
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	26.54	7.19	3.32
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	50.65	19.11	7.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	51.11	18.72	7.99
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	27.31	12.84	4.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	44.41	16.73	8.15
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	37.57	14.67	6.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	32.63	12.70	5.91
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.36	15.72	4.06
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	11.60	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	29.90	11.69	5.16
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	39.70	15.88	4.41
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	5.45	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	52.38	18.74	7.21
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	44.43	18.01	7.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	9.60	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	37.04	16.52	5.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	53.89	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	4.08	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	52.11	18.83	9.20
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	29.80	5.52	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.17	5.12	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	40.66	21.07	7.44
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	27.14	11.13	2.78
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	11.05	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	29.74	20.85	5.81
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	25.38	11.82	6.13
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.30	6.75	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	36.47	15.15	7.01
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	33.25	17.46	5.82
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.41	2.91	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	24.13	9.95	2.41
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	52.59	19.20	7.93
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	10.16	7.39
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	42.68	16.50	7.40
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.06	6.36	2.90
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	33.69	12.70	7.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	35.61	13.73	8.15
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	6.99	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.02	6.67	2.94
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	46.99	19.16	5.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	15.26	7.49	1.98
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	26.76	10.83	7.01
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	44.01	19.46	7.08
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.76	4.55	2.65
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	28.69	14.21	6.82
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	49.65	21.63	9.09
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	2.61	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.93	10.58	2.35
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	51.03	17.88	6.63
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.61	10.72	4.53
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	26.80	10.72	4.17
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	79.10	18.83	15.07
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	62.38	14.26	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.14	7.89	4.27
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	58.91	16.83	7.36
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	67.41	22.14	7.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	47.50	15.83	3.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	54.08	16.15	10.51
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	50.87	20.77	8.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	53.50	10.52	7.46
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	27.26	7.37	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	27.48	7.69	4.03
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	10.89	7.78
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	97.80	24.58	16.57
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	27.05	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	46.46	10.10	9.09
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	51.44	16.44	9.70
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	66.74	24.51	13.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	108.72	29.88	17.80
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	137.67	43.73	14.58
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	61.93	12.08	12.08
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	5.71	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	58.72	16.31	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	52.28	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	62.48	8.83	15.30
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	36.58	7.84	6.79
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.02	5.34	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.69	0.83	2.50
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	76.63	23.20	20.92
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	60.64	11.17	33.51
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	4.08	5.44
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	45.94	34.92	45.94
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.88	2.51	3.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	34.40	9.07	5.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.24	4.59	4.05
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	29.85	7.36	9.46
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.37	6.95	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	32.21	7.04	7.04
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	15.19	3.63	4.53
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.66	3.92	5.06
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	35.90	9.30	9.48
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.44	4.24	4.24
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.80	3.60	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	65.64	20.35	18.05
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.31	1.95	2.44
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.10	5.82	6.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	13.36	2.11	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.71	3.68	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	19.60	3.21	3.21
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	68.63	13.80	15.86
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	55.63	25.28	17.70
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.62	6.91	6.46
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.13	7.62	3.39
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.79	6.65	6.41
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	24.04	4.29	4.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.99	1.00	5.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.64	4.06	4.96
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	16.67	3.17	9.52
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	2.79	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	34.43	5.68	8.70
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	11.41	0.98	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.15	3.49	3.05
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	21.26	5.43	4.07
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	1.76	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	0.00	3.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.36	0.99	3.47
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.57	1.91	3.06
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	41.44	9.07	10.28
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	29.18	8.18	8.84
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	4.07	4.74
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	10.22	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	1.22	7.93
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.63	2.52	3.46
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.11	2.72	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.99	6.33	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	62.35	13.60	19.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	55.64	40.46
Myoblast, donor1	11241-116D8	48.57	13.04	14.16
Myoblast, donor2	11322-117D8	48.52	9.01	13.43
Myoblast, donor3	11398-118D3	62.72	13.12	15.64
NK T cell leukemia cell line:KHYG-1	10777-110G3	25.68	11.09	4.67
Natural Killer Cells, donor1	11230-116C6	11.69	7.38	2.15
Natural Killer Cells, donor2	11311-117C6	9.65	3.02	0.90
Natural Killer Cells, donor3	11387-118C1	9.57	2.76	0.74
Neural stem cells, donor1	11275-116H6	39.56	7.98	9.80
Neural stem cells, donor2	11352-117H2	32.74	9.63	3.85
Neurons, donor1	11494-119E9	88.76	19.34	15.93
Neurons, donor2	11574-120E8	81.24	18.93	12.99
Neurons, donor3	11655-122E8	96.19	28.78	15.62
Neutrophils, donor1	11233-116C9	41.76	25.06	1.86
Neutrophils, donor2	11314-117C9	37.69	17.39	11.60
Neutrophils, donor3	11390-118C4	69.03	45.20	3.05
Nucleus Pulposus Cell, donor1	11252-116F1	33.60	4.99	6.06
Nucleus Pulposus Cell, donor2	11409-118E5	34.19	9.12	8.14
Nucleus Pulposus Cell, donor3	11462-119B4	60.37	6.02	8.82
Olfactory epithelial cells, donor1	11933-125I7	28.91	3.99	7.43
Olfactory epithelial cells, donor2	11934-125I8	41.54	6.08	12.59
Olfactory epithelial cells, donor3	11935-125I9	35.07	6.13	10.56
Olfactory epithelial cells, donor4	11936-126A1	34.77	6.23	7.60
Oligodendrocyte - precursors, donor1	11496-119F2	49.95	8.43	7.22
Osteoblast - differentiated, donor1	11276-116H7	30.42	4.68	4.25
Osteoblast - differentiated, donor2	11353-117H3	37.72	3.43	14.86
Osteoblast - differentiated, donor3	11425-118G3	30.41	6.83	7.45
Osteoblast, donor1	11277-116H8	59.80	11.34	12.31
Osteoblast, donor2	11354-117H4	53.38	19.66	16.15
Osteoblast, donor3	11426-118G4	41.23	5.33	12.26
Pancreatic stromal cells, donor1	11249-116E7	50.12	11.03	9.10
Pericytes, donor1	11491-119E6	43.39	7.12	13.24
Pericytes, donor2	11571-120E5	48.22	7.47	12.90
Pericytes, donor3	11652-122E5	53.51	9.77	15.26
Perineurial Cells, donor1	11499-119F5	59.45	11.19	10.85
Perineurial Cells, donor2	11579-120F4	73.70	12.61	15.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	16.89	3.82	2.55
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.00	2.45	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	9.97	2.72	1.55
Placental Epithelial Cells, donor1	11278-116H9	49.03	8.61	7.89
Placental Epithelial Cells, donor2	11355-117H5	32.16	6.65	7.76
Placental Epithelial Cells, donor3	11427-118G5	19.63	3.73	3.73
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	42.09	4.11	9.49
Preadipocyte - breast, donor1	11467-119B9	35.08	6.38	10.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	30.28	3.79	7.18
Preadipocyte - breast, donor2	11328-117E5	43.23	6.98	11.03
Preadipocyte - omental, donor1	11468-119C1	36.76	7.46	9.91
Preadipocyte - omental, donor2	11329-117E6	52.38	5.24	10.48
Preadipocyte - omental, donor3	11403-118D8	50.71	8.59	13.61
Preadipocyte - perirenal, donor1	11469-119C2	44.29	2.95	14.76
Preadipocyte - subcutaneous, donor1	11279-116I1	23.34	5.84	3.99
Preadipocyte - subcutaneous, donor2	11356-117H6	69.95	16.11	15.94
Preadipocyte - subcutaneous, donor3	11428-118G6	78.67	17.54	15.67
Preadipocyte - visceral, donor1	11280-116I2	64.18	14.34	14.72
Preadipocyte - visceral, donor2	11357-117H7	50.16	12.42	12.89
Preadipocyte - visceral, donor3	11429-118G7	72.20	14.42	17.45
Prostate Epithelial Cells (polarized), donor1	11253-116F2	38.47	14.78	8.75
Prostate Epithelial Cells, donor2	11331-117E8	24.78	4.74	4.06
Prostate Epithelial Cells, donor3	11404-118D9	9.12	3.37	1.16
Prostate Stromal Cells, donor1	11254-116F3	49.32	12.98	14.12
Prostate Stromal Cells, donor2	11332-117E9	52.71	12.19	12.55
Prostate Stromal Cells, donor3	11405-118E1	37.64	6.67	8.34
Renal Cortical Epithelial Cells, donor1	11516-119H4	47.81	6.57	12.41
Renal Cortical Epithelial Cells, donor2	11596-120H3	43.87	8.04	10.54
Renal Epithelial Cells, donor1	11517-119H5	25.36	7.10	13.19
Renal Epithelial Cells, donor2	11597-120H4	58.33	6.40	16.36
Renal Epithelial Cells, donor3	11678-122H4	47.85	7.20	10.48
Renal Glomerular Endothelial Cells, donor1	11514-119H2	46.30	3.40	15.66
Renal Glomerular Endothelial Cells, donor2	11594-120H1	60.78	11.32	11.19
Renal Glomerular Endothelial Cells, donor3	11675-122H1	58.83	10.43	11.10
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.29	3.33	7.99
Renal Mesangial Cells, donor1	11518-119H6	65.59	9.02	15.63
Renal Mesangial Cells, donor2	11598-120H5	73.36	7.52	11.29
Renal Mesangial Cells, donor3	11679-122H5	38.28	6.38	10.82
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	76.23	7.25	14.23
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	48.92	4.22	10.54
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	50.53	9.26	13.50
Retinal Pigment Epithelial Cells, donor0	11215-116A9	67.67	12.45	12.70
Retinal Pigment Epithelial Cells, donor1	11528-119I7	46.05	7.39	9.38
Retinal Pigment Epithelial Cells, donor2	11608-120I6	42.19	14.41	9.26
Retinal Pigment Epithelial Cells, donor3	11689-122I6	31.36	6.27	6.52
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	47.84	12.03	10.16
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	48.24	19.65	4.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	29.72	13.76	4.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	26.68	11.02	5.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	47.07	14.95	8.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	38.83	15.39	7.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	52.98	18.96	10.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	56.32	17.74	10.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	44.29	18.30	6.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	42.99	17.57	8.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	42.30	14.38	6.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	33.43	10.89	6.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	60.75	23.29	11.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	49.64	11.62	6.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	35.09	12.99	7.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	46.47	19.25	7.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	40.53	12.43	4.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	31.77	14.72	6.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	46.41	16.54	6.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	38.88	10.09	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	34.46	12.56	7.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	46.21	16.61	6.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.36	9.18	6.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	32.52	14.30	7.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	38.79	14.87	9.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	35.92	12.76	5.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	34.34	13.12	6.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	44.73	17.33	7.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	57.32	16.28	7.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	33.53	13.89	7.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	45.13	18.47	8.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	51.84	13.89	8.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	41.59	13.94	9.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	32.79	12.74	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	49.80	12.11	8.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	33.21	11.24	6.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	37.40	13.69	5.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	45.56	16.85	6.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	33.19	12.35	5.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	41.86	13.79	9.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	34.94	10.57	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	38.62	17.02	6.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	36.25	14.13	7.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	25.99	6.91	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	38.10	11.91	7.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	31.04	12.70	5.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	37.58	10.92	4.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	30.05	11.18	4.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	26.59	6.04	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.85	14.56	6.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	34.64	14.56	5.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	36.51	15.82	5.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	58.17	14.47	5.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	20.58	10.40	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.06	9.29	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	28.57	7.91	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.91	8.54	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	32.45	12.02	2.40
Schwann Cells, donor1	11498-119F4	68.83	10.91	18.43
Schwann Cells, donor2	11578-120F3	78.26	13.61	0.00
Schwann Cells, donor3	11659-122F3	54.55	12.05	12.93
Sebocyte, donor1	11220-116B5	14.79	3.29	6.03
Sebocyte, donor2	11301-117B5	17.00	5.51	3.22
Sebocyte, donor3	11378-118B1	25.76	5.15	5.15
Sertoli Cells, donor1	11255-116F4	48.04	16.57	8.28
Sertoli Cells, donor2	11333-117F1	56.49	5.65	5.65
Skeletal Muscle Cells, donor1	11281-116I3	20.41	3.78	4.49
Skeletal Muscle Cells, donor2	11358-117H8	18.79	0.72	3.61
Skeletal Muscle Cells, donor3	11430-118G8	48.49	12.54	11.70
Skeletal Muscle Cells, donor4	11451-119A2	92.53	21.36	18.07
Skeletal Muscle Cells, donor5	11455-119A6	89.63	16.20	20.22
Skeletal Muscle Cells, donor6	11459-119B1	93.88	22.32	17.70
Skeletal Muscle Satellite Cells, donor1	11240-116D7	71.95	20.16	14.24
Skeletal Muscle Satellite Cells, donor2	11321-117D7	67.35	13.27	12.41
Skeletal Muscle Satellite Cells, donor3	11397-118D2	81.05	18.16	15.28
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	36.14	7.67	11.37
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	1.45	11.58
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	35.64	6.05	9.63
Skin - palm, donor1	10286-104F7	26.86	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	26.09	5.77	4.04
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	34.35	9.00	5.73
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	25.97	4.15	4.67
Small Airway Epithelial Cells, donor1	11256-116F5	20.02	4.59	3.48
Small Airway Epithelial Cells, donor2	11334-117F2	13.78	4.08	1.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	33.62	6.55	3.81
Small Airway Epithelial Cells, donor3	11406-118E2	7.27	2.47	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	52.15	6.48	6.79
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	22.90	3.78	4.45
Smooth Muscle Cells - Aortic, donor0	11210-116A4	33.51	6.47	7.64
Smooth Muscle Cells - Aortic, donor1	11283-116I5	41.77	4.64	4.20
Smooth Muscle Cells - Aortic, donor2	11360-117I1	42.92	7.48	8.66
Smooth Muscle Cells - Aortic, donor3	11432-118H1	42.49	14.68	6.95
Smooth Muscle Cells - Bladder, donor1	11519-119H7	36.03	9.01	6.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	35.40	7.72	8.78
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	59.85	11.30	10.20
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	49.42	8.32	14.85
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	77.16	13.67	13.02
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	86.83	12.70	10.93
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	42.14	10.11	9.82
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	51.41	7.00	14.32
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	34.40	6.09	8.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	32.33	6.82	5.56
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	32.90	5.25	5.72
Smooth Muscle Cells - Colonic, donor1	11239-116D6	55.16	11.95	11.65
Smooth Muscle Cells - Colonic, donor2	11320-117D6	46.28	11.62	8.18
Smooth Muscle Cells - Colonic, donor3	11396-118D1	57.41	13.01	9.55
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	35.89	8.51	6.81
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	37.73	6.47	11.86
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	47.22	10.76	11.66
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	36.19	8.88	9.56
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	37.93	9.34	5.81
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	30.80	5.54	7.55
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	40.73	13.43	7.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	45.29	4.83	9.06
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	77.89	17.22	16.69
Smooth Muscle Cells - Prostate, donor1	11257-116F6	66.58	11.72	10.39
Smooth Muscle Cells - Prostate, donor2	11335-117F3	49.96	9.27	11.02
Smooth Muscle Cells - Prostate, donor3	11465-119B7	37.80	6.85	8.88
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	52.47	9.95	10.86
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	49.51	4.50	5.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	321.76	7.75	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	31.62	6.05	7.44
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	35.85	4.54	10.10
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	29.77	5.95	5.01
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	40.12	9.73	6.19
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	75.48	20.33	12.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	32.23	7.47	3.27
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	28.50	5.76	6.62
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	36.46	7.14	8.67
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	37.98	6.39	8.27
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	72.67	15.51	12.30
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	60.83	10.05	11.14
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	21.90	5.24	5.71
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	28.87	6.61	5.87
Smooth Muscle Cells - Uterine, donor1	11258-116F7	49.05	7.73	8.62
Smooth Muscle Cells - Uterine, donor3	11466-119B8	76.66	21.36	14.63
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	28.38	9.52	6.41
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	39.14	12.43	10.58
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	52.44	17.85	7.44
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	43.48	9.34	10.42
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	46.84	17.03	12.21
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	78.77	16.54	22.84
Smooth muscle cells - airway, control, donor1	11966-126D4	45.97	8.63	10.67
Smooth muscle cells - airway, control, donor2	11967-126D5	35.54	9.58	7.99
Smooth muscle cells - airway, control, donor3	11968-126D6	48.91	12.12	11.70
Smooth muscle cells - airway, control, donor4	11969-126D7	42.63	6.42	13.75
Synoviocyte, donor1	11291-117A4	48.64	8.25	10.94
Synoviocyte, donor2	11368-117I9	38.89	6.20	9.05
Synoviocyte, donor3	11440-118H9	45.35	4.69	10.50
Trabecular Meshwork Cells, donor1	11532-120A2	57.89	13.58	14.29
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	9.91	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	22.23	4.86	7.41
Tracheal Epithelial Cells, donor1	11292-117A5	21.00	5.02	3.87
Tracheal Epithelial Cells, donor2	11369-118A1	14.69	3.09	2.32
Tracheal Epithelial Cells, donor3	11441-118I1	20.04	1.15	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	52.41	10.95	10.70
Urethra, donor2	10319-105A4	12.59	10.79	5.40
Urothelial Cells, donor1	11520-119H8	32.15	5.31	6.38
Urothelial Cells, donor2	11600-120H7	23.23	7.21	4.81
Urothelial Cells, donor3	11681-122H7	18.11	4.35	3.21
Urothelial cells, donor0	11216-116B1	22.74	4.68	3.57
Whole blood (ribopure), donor090309, donation1	12179-129A1	34.70	15.13	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	77.20	10.01	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.28	9.58	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	33.06	13.77	3.10
Whole blood (ribopure), donor090325, donation2	12177-128I8	36.60	11.04	5.23
Whole blood (ribopure), donor090612, donation1	12182-129A4	54.14	15.62	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	55.07	16.52	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	28.30	11.87	3.65
Wilms' tumor cell line:G-401	10809-111A8	42.56	11.97	7.65
Wilms' tumor cell line:HFWT	10597-108E3	32.56	4.40	6.16
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	40.78	10.89	5.59
achilles tendon, donor2	10292-104G4	8.27	6.20	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	60.68	29.07	13.26
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	55.26	22.06	11.14
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	43.09	15.91	9.73
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	91.16	34.56	15.78
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	46.10	17.15	9.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	67.04	22.21	12.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	30.22	9.80	9.80
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	64.77	15.42	11.90
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	53.90	15.52	10.62
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	40.77	11.65	7.77
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	24.29	13.80	2.94
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	62.41	19.50	23.40
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	61.58	15.34	13.25
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	97.86	35.73	15.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	37.41	12.86	4.38
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.42	8.37	3.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	36.19	9.87	4.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	33.15	10.13	5.83
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	48.64	13.65	10.24
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	54.59	11.22	9.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	59.69	18.53	9.87
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	40.76	17.15	7.80
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	59.04	16.34	12.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	79.90	16.72	22.30
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	111.11	32.39	23.35
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	38.82	8.29	8.72
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	9.37	5.62
adenocarcinoma cell line:IM95m	10796-110I4	42.39	13.89	5.65
adipose tissue, adult, pool1	10010-101C1	33.20	6.83	5.43
adipose, donor1	10184-103D4	121.97	42.22	33.43
adipose, donor2	10185-103D5	32.04	8.92	6.08
adipose, donor3	10186-103D6	47.11	11.71	11.98
adipose, donor4	10187-103D7	70.21	39.00	12.13
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	58.24	6.31	14.68
adrenal gland, adult, pool1	10081-102A9	36.38	3.64	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	42.02	13.47	8.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	88.61	21.80	19.29
amniotic membrane cells, donor1	12235-129G3	68.63	7.19	12.29
amniotic membrane cells, donor2	12236-129G4	101.09	11.83	15.21
amniotic membrane cells, donor3	12237-129G5	49.79	5.60	6.19
amygdala - adult, donor10196	10167-103B5	54.55	22.53	7.11
amygdala, adult, donor10252	10151-102I7	39.34	17.24	7.50
amygdala, newborn, donor10223	10360-105E9	54.87	27.76	12.91
anaplastic carcinoma cell line:8305C	10428-106D5	61.12	13.88	15.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	107.88	29.78	15.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	75.16	21.04	9.35
aorta, adult, pool1	10052-101G7	28.64	4.12	5.69
appendix, adult	10189-103D9	19.41	6.99	3.88
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	59.16	8.94	13.76
artery, adult	10190-103E1	88.31	29.89	8.15
astrocytoma cell line:TM-31	10425-106D2	60.26	9.13	12.02
b cell line:RPMI1788	10427-106D4	23.49	6.69	5.65
basal cell carcinoma cell line:TE 354.T	10702-109G9	56.60	13.32	13.32
bile duct carcinoma cell line:HuCCT1	10432-106D9	51.40	9.23	9.13
bile duct carcinoma cell line:TFK-1	10496-107C1	22.09	8.20	2.85
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	24.61	10.63	4.47
bladder, adult, pool1	10011-101C2	31.18	5.76	4.13
blood, adult, pool1	10053-101G8	15.50	13.29	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	54.81	17.13	11.99
bone marrow, adult	10192-103E3	33.74	5.40	10.12
brain, adult, donor1	10084-102B3	52.28	12.30	12.30
brain, adult, pool1	10012-101C3	51.22	13.70	8.91
brain, fetal, pool1	10085-102B4	69.46	16.03	16.03
breast carcinoma cell line:MCF7	10482-107A5	31.05	5.62	12.22
breast carcinoma cell line:MDA-MB-453	10419-106C5	73.65	16.10	13.73
breast, adult, donor1	10080-102A8	24.62	5.68	6.31
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	45.61	5.97	12.83
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.07	7.11	6.49
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	107.97	11.97	35.22
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.96	7.99	4.60
carcinoid cell line:NCI-H1770	10703-109H1	85.10	31.03	18.81
carcinoid cell line:NCI-H727	10735-110B6	18.16	3.06	5.36
carcinoid cell line:SK-PN-DW	10719-109I8	48.80	38.03	6.65
carcinosarcoma cell line:JHUCS-1	10642-109A3	84.11	15.70	14.11
caudate nucleus - adult, donor10196	10177-103C6	72.53	19.57	19.57
caudate nucleus, adult, donor10252	10164-103B2	59.40	17.23	9.54
caudate nucleus, adult, donor10258	10379-105H1	119.97	33.62	19.87
caudate nucleus, newborn, donor10223	10354-105E3	65.56	24.17	10.62
cerebellum - adult, donor10196	10173-103C2	55.35	23.31	17.48
cerebellum, adult, donor10252	10166-103B4	51.03	11.53	5.34
cerebellum, adult, pool1	10083-102B2	66.92	13.45	10.00
cerebellum, newborn, donor10223	10357-105E6	96.31	26.57	21.59
cerebral meninges, adult	10188-103D8	56.73	22.44	14.12
cerebrospinal fluid, donor2	10294-104G6	41.66	10.23	6.58
cervical cancer cell line:D98-AH2	10552-107I3	72.61	16.97	9.35
cervical cancer cell line:ME-180	10553-107I4	59.00	19.06	5.47
cervix, adult, pool1	10013-101C4	33.18	6.09	6.09
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	71.20	16.02	13.52
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	1.31	2.61
choriocarcinoma cell line:BeWo	10423-106C9	29.33	7.58	5.10
choriocarcinoma cell line:SCH	10785-110H2	34.62	4.81	7.64
choriocarcinoma cell line:T3M-3	10618-108G6	36.53	6.40	7.83
chorionic membrane cells, donor1	12238-129G6	44.73	9.69	7.69
chorionic membrane cells, donor2	12239-129G7	68.51	12.33	12.63
chorionic membrane cells, donor3	12240-129G8	36.82	4.40	9.34
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	92.90	36.35	17.17
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	43.03	12.29	6.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	53.64	20.91	9.93
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	40.83	12.84	7.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	39.91	11.37	7.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	36.65	12.01	6.52
chronic myelogenous leukemia cell line:K562	10454-106G4	120.14	40.63	18.55
chronic myelogenous leukemia cell line:KU812	10409-106B4	31.80	17.72	7.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	47.32	8.00	12.34
clear cell carcinoma cell line:TEN	10636-108I6	39.04	5.55	9.72
colon carcinoma cell line:CACO-2	10513-107D9	81.64	23.98	17.57
colon carcinoma cell line:COLO-320	10420-106C6	52.45	14.44	8.74
colon, adult, donor1	10082-102B1	47.60	11.90	9.52
colon, adult, pool1	10014-101C5	39.60	10.22	5.41
colon, fetal, donor1	10070-101I7	22.87	6.18	6.18
common myeloid progenitor CMP, donor1	12130-128D6	18.33	32.08	4.58
common myeloid progenitor CMP, donor2	12134-128E1	150.22	75.11	50.07
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	27.20	14.45	15.72
cord blood derived cell line:COBL-a 24h infection	10453-106G3	29.73	17.36	11.32
cord blood derived cell line:COBL-a untreated	10449-106F8	35.53	19.88	10.43
corpus callosum, adult, pool1	10042-101F6	47.10	10.17	10.84
cruciate ligament, donor2	10295-104G7	21.88	4.86	7.29
diaphragm, fetal, donor1	10069-101I6	70.63	14.45	11.24
diencephalon, adult	10193-103E4	60.24	14.88	14.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.26	11.94	2.30
ductal cell carcinoma cell line:KLM-1	10438-106E6	67.70	10.77	13.08
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	27.68	9.15	8.43
ductus deferens, adult	10196-103E7	38.87	6.48	9.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	7.20	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.76	13.98	6.62
dura mater, adult, donor1	10041-101F5	25.02	5.37	6.36
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	33.09	17.10	9.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	71.50	22.93	17.63
embryonic pancreas cell line:1B2C6	10604-108F1	29.60	3.08	6.78
embryonic pancreas cell line:1C3D3	10605-108F2	29.36	3.03	5.45
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.32	3.40	3.09
embryonic pancreas cell line:2C6	10603-108E9	23.64	2.63	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	26.48	5.36	7.04
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.75	4.89	10.51
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	71.24	15.60	11.26
epidermoid carcinoma cell line:A431	10426-106D3	44.46	7.67	10.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	44.98	11.00	9.46
epididymis, adult	10197-103E8	39.56	8.79	7.54
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	31.40	4.08	8.69
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	27.92	6.29	5.90
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	63.30	15.73	13.76
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	48.62	10.43	9.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	63.52	14.23	15.80
esophagus, adult, pool1	10015-101C6	37.91	8.60	7.01
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	33.81	7.76	5.01
eye - muscle inferior rectus, donor1	10272-104E2	19.32	12.07	4.83
eye - muscle lateral, donor2	10298-104H1	48.40	14.73	12.63
eye - muscle medial, donor2	10299-104H2	46.13	16.37	5.95
eye - muscle superior, donor2	10297-104G9	34.39	9.17	2.29
eye - vitreous humor, donor1	10268-104D7	14.57	7.29	5.83
eye, fetal, donor1	10054-101G9	46.27	5.85	7.88
fibrosarcoma cell line:HT-1080	10758-110E2	46.29	9.49	11.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	55.08	9.97	12.11
frontal lobe, adult, pool1	10040-101F4	54.14	15.20	9.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	59.45	14.71	13.51
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	39.68	7.31	7.59
gall bladder, adult	10198-103E9	36.70	7.24	7.73
gamma delta positive T cells, donor1	11937-126A2	41.34	10.20	2.68
gamma delta positive T cells, donor2	11938-126A3	31.37	10.83	2.99
gastric adenocarcinoma cell line:MKN1	10614-108G2	58.93	10.56	16.05
gastric adenocarcinoma cell line:MKN45	10612-108F9	22.05	1.55	4.26
gastric cancer cell line:AZ521	10549-107H9	73.62	10.66	12.13
gastric cancer cell line:GSS	10560-108A2	75.05	5.49	19.22
gastrointestinal carcinoma cell line:ECC12	10615-108G3	56.66	14.39	17.13
giant cell carcinoma cell line:LU65	10487-107B1	55.19	15.03	6.88
giant cell carcinoma cell line:Lu99B	10433-106E1	73.48	7.98	15.68
glassy cell carcinoma cell line:HOKUG	10688-109F4	27.93	8.98	4.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	41.38	7.81	10.77
glioblastoma cell line:A172, tech_rep2	10444-106F3	45.64	6.60	8.85
glioblastoma cell line:T98G	10485-107A8	60.93	12.25	14.24
glioma cell line:GI-1	10413-106B8	25.19	7.03	9.37
globus pallidus - adult, donor10196	10175-103C4	66.33	24.05	11.66
globus pallidus, adult, donor10252	10161-103A8	48.82	11.72	11.96
globus pallidus, adult, donor10258	10367-105F7	78.04	8.22	9.58
globus pallidus, newborn, donor10223	10364-105F4	53.29	15.99	15.99
granulocyte macrophage progenitor, donor1	12131-128D7	44.05	17.13	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	43.71	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	99.31	62.72	20.91
granulosa cell tumor cell line:KGN	10624-108H3	40.00	6.72	8.96
hIPS +CCl2, biol_rep1	14383-156B9	73.46	31.22	8.72
hIPS +CCl2, biol_rep2	14384-156C1	58.53	25.15	10.52
hIPS +CCl2, biol_rep3	14385-156C2	88.24	30.92	10.31
hIPS, biol_rep1	14380-156B6	58.93	31.62	14.37
hIPS, biol_rep2	14381-156B7	96.02	21.95	9.60
hIPS, biol_rep3	14382-156B8	105.93	24.28	11.03
hairy cell leukemia cell line:Mo	10712-109I1	32.76	18.39	8.33
heart - mitral valve, adult	10205-103F7	54.11	11.36	13.45
heart - pulmonic valve, adult	10206-103F8	81.32	13.86	23.79
heart - tricuspid valve, adult	10207-103F9	35.80	7.49	14.99
heart, adult, diseased post-infarction, donor1	10050-101G5	59.99	8.16	17.34
heart, adult, diseased, donor1	10051-101G6	100.92	10.65	29.38
heart, adult, pool1	10016-101C7	114.07	16.79	31.74
heart, fetal, pool1	10046-101G1	87.38	15.92	23.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	30.54	3.70	3.39
hepatoblastoma cell line:HuH-6	10633-108I3	23.78	1.19	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	37.57	13.26	7.40
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	37.26	15.66	5.83
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	36.28	13.95	5.86
hepatoma cell line:Li-7	10484-107A7	35.03	7.90	4.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	32.86	22.51	4.42
hippocampus - adult, donor10196	10169-103B7	49.21	18.93	11.36
hippocampus, adult, donor10252	10153-102I9	37.35	11.63	6.74
hippocampus, adult, donor10258	10374-105G5	73.70	17.43	15.93
hippocampus, newborn, donor10223	10363-105F3	47.23	14.45	11.28
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	175.17	81.18	30.52
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	64.80	26.90	9.23
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	82.01	51.03	16.50
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	42.29	18.61	6.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	45.19	13.43	7.49
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	59.22	20.50	9.49
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.38	13.72	9.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	37.27	11.20	7.54
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.95	12.51	7.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	89.74	28.42	20.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	56.89	16.23	11.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	110.42	30.97	20.20
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	48.20	24.41	9.08
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	63.38	32.92	8.84
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	97.75	67.20	25.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	41.05	9.35	5.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	48.40	10.90	11.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	73.96	21.99	11.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	26.94	6.41	6.03
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	28.19	8.64	4.55
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	36.34	13.78	8.46
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	46.87	14.86	9.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	42.09	11.61	7.84
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	53.81	19.13	10.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	62.81	30.11	10.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	61.62	23.96	9.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	129.43	71.05	17.97
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	58.80	9.15	13.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	47.51	11.72	9.50
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	56.89	10.59	16.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	44.47	8.79	5.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	40.51	7.97	9.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	48.23	12.83	9.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	54.45	12.53	16.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	68.15	15.90	14.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	71.24	21.17	17.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	60.62	18.11	11.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	92.25	47.24	13.82
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	77.07	34.15	10.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	50.43	11.92	7.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	143.14	52.05	48.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	72.15	25.81	13.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	41.05	8.21	9.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	36.55	10.49	9.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	37.01	11.39	11.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	53.70	11.93	13.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	59.05	15.57	15.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	64.92	16.43	11.85
immature langerhans cells, donor1	11904-125F5	25.91	7.02	6.54
immature langerhans cells, donor2	11905-125F6	32.48	7.92	4.75
insula, adult, pool1	10039-101F3	57.63	17.41	10.13
keratoacanthoma cell line:HKA-1	10791-110H8	41.62	16.26	11.38
kidney, adult, pool1	10017-101C8	68.09	15.82	15.52
kidney, fetal, pool1	10045-101F9	39.19	6.79	8.98
large cell lung carcinoma cell line:IA-LM	10509-107D5	21.16	5.11	4.83
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.50	3.73	8.85
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	27.34	5.69	4.04
left atrium, adult, donor1	10079-102A7	65.93	17.44	25.06
left ventricle, adult, donor1	10078-102A6	100.12	16.69	31.86
leiomyoblastoma cell line:G-402	10721-110A1	41.04	6.29	8.21
leiomyoma cell line:10964C	10569-108B2	47.42	10.06	11.14
leiomyoma cell line:15242A	10570-108B3	45.65	13.59	9.78
leiomyoma cell line:15425	10571-108B4	47.35	9.23	13.84
leiomyosarcoma cell line:Hs 5.T	10722-110A2	120.64	44.45	50.79
lens epithelial cell line:SRA 01/04	10647-109A8	51.23	14.64	14.64
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	26.80	12.99	5.67
liposarcoma cell line:KMLS-1	10782-110G8	23.59	4.37	3.91
liposarcoma cell line:SW 872	10726-110A6	58.36	12.79	15.96
liver, adult, pool1	10018-101C9	52.51	15.23	8.27
liver, fetal, pool1	10086-102B5	33.87	11.29	9.41
locus coeruleus - adult, donor10196	10182-103D2	40.98	13.42	10.94
locus coeruleus, adult, donor10252	10165-103B3	46.32	14.21	9.97
locus coeruleus, adult, donor10258	10375-105G6	42.60	16.08	7.62
locus coeruleus, newborn, donor10223	10362-105F2	51.32	17.67	15.98
lung adenocarcinoma cell line:A549	10499-107C4	46.78	6.50	12.32
lung adenocarcinoma cell line:PC-14	10408-106B3	32.40	2.07	4.14
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	66.83	18.98	10.28
lung, adult, pool1	10019-101D1	30.95	3.90	5.08
lung, fetal, donor1	10068-101I5	46.24	5.71	9.42
lung, right lower lobe, adult, donor1	10075-102A3	35.28	8.25	7.33
lymph node, adult, donor1	10077-102A5	19.41	6.63	1.89
lymphangiectasia cell line:DS-1	10727-110A7	45.81	8.11	8.11
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	35.17	19.02	6.79
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	16.99	5.10	4.25
mature adipocyte, donor1	12231-129F8	79.47	27.08	11.54
mature adipocyte, donor2	12232-129F9	67.65	27.19	12.66
mature adipocyte, donor3	12233-129G1	74.91	24.18	9.01
mature adipocyte, donor4	12234-129G2	80.28	29.22	14.48
maxillary sinus tumor cell line:HSQ-89	10414-106B9	36.45	7.86	9.05
medial frontal gyrus - adult, donor10196	10170-103B8	55.27	10.15	11.28
medial frontal gyrus, adult, donor10252	10150-102I6	43.95	11.59	5.15
medial frontal gyrus, adult, donor10258	10368-105F8	80.06	25.10	13.34
medial frontal gyrus, newborn, donor10223	10352-105E1	95.11	43.93	22.18
medial temporal gyrus - adult, donor10196	10183-103D3	58.73	17.55	14.18
medial temporal gyrus, adult, donor10252	10156-103A3	44.78	13.37	7.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	92.46	25.04	19.26
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	43.06	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	55.28	21.89	14.00
medulla oblongata - adult, donor10196	10174-103C3	61.65	11.03	14.93
medulla oblongata, adult, donor10252	10155-103A2	36.07	12.85	7.74
medulla oblongata, adult, pool1	10038-101F2	41.63	10.69	9.96
medulla oblongata, newborn, donor10223	10361-105F1	46.87	12.50	12.15
medulloblastoma cell line:D283 Med	10838-111E1	51.59	11.96	10.85
medulloblastoma cell line:ONS-76	10759-110E3	63.95	8.68	10.03
melanoma cell line:COLO 679	10514-107E1	37.37	8.48	7.33
melanoma cell line:G-361	10465-106H6	16.56	5.70	4.34
meningioma cell line:HKBMM	10691-109F7	35.82	5.97	5.25
merkel cell carcinoma cell line:MKL-1	10843-111E6	73.14	21.15	17.62
merkel cell carcinoma cell line:MS-1	10844-111E7	106.02	40.18	17.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	85.77	13.96	23.78
mesenchymal precursor cell - adipose, donor2	11748-123G2	38.72	8.36	11.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	68.74	12.42	10.77
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	47.06	6.46	11.10
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	51.42	11.36	10.78
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	49.97	11.11	9.02
mesenchymal precursor cell - cardiac, donor1	11752-123G6	40.33	7.72	11.33
mesenchymal precursor cell - cardiac, donor2	11753-123G7	45.55	5.18	10.70
mesenchymal precursor cell - cardiac, donor3	11754-123G8	71.89	13.26	18.44
mesenchymal precursor cell - cardiac, donor4	11755-123G9	61.85	16.88	15.39
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	56.48	9.25	10.39
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.01	5.27	8.23
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	60.19	12.18	12.59
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	73.31	13.27	15.36
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	64.11	11.02	13.07
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	39.54	5.75	10.42
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	49.97	4.97	9.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	32.15	5.70	6.38
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	67.55	13.43	13.01
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	63.66	16.44	13.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.54	5.34	12.95
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	42.34	8.47	8.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	38.63	6.58	7.73
mesenchymal stem cell line:Hu5/E18	10568-108B1	102.31	21.89	26.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	59.82	11.42	17.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	51.92	8.70	14.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	54.71	7.59	13.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	49.60	11.40	12.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	55.31	8.47	16.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	57.88	7.78	18.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	62.88	9.04	15.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	49.58	10.19	17.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	65.76	12.11	17.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	55.78	8.25	12.49
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	58.65	8.65	16.10
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	42.53	10.27	16.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	51.69	9.73	11.08
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	53.63	13.51	11.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	58.42	13.75	16.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	68.36	10.94	21.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	72.31	20.66	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	74.38	12.67	20.14
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	45.10	10.18	16.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	56.51	9.60	18.12
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	50.70	10.63	17.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	59.09	9.72	14.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	8.39	18.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	46.69	11.92	18.88
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	14.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	66.41	7.12	22.53
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	51.18	8.53	10.97
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	54.10
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	55.74	9.50	15.83
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	43.80	10.69	9.66
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	42.98	10.75	10.75
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	3.44	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	43.19	11.00	10.19
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	46.08	7.94	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	35.37	8.25	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	37.72	10.91	5.92
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	48.12	10.69	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	62.68	16.56	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	66.77	25.68	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	57.83	20.65	11.01
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	78.67	38.10	13.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	56.08	37.01	15.70
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	72.51	41.34	11.45
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	93.09	36.27	20.96
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	78.50	50.15	15.26
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	70.96	25.34	21.54
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	62.51	18.81	12.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	27.11	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	62.60	26.36	7.41
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	80.76	31.95	14.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	65.22	19.15	9.73
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	60.10	18.34	14.26
mesodermal tumor cell line:HIRS-BM	10696-109G3	66.54	16.25	9.28
mesothelioma cell line:ACC-MESO-1	10493-107B7	68.75	7.32	9.21
mesothelioma cell line:ACC-MESO-4	10494-107B8	54.91	13.90	13.21
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	72.65	29.92	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	90.83	27.95	17.78
mesothelioma cell line:Mero-25	10850-111F4	18.61	6.81	4.54
mesothelioma cell line:Mero-41	10851-111F5	63.56	8.07	15.65
mesothelioma cell line:Mero-48a	10852-111F6	139.50	31.44	30.78
mesothelioma cell line:Mero-82	10853-111F7	38.37	8.94	8.41
mesothelioma cell line:Mero-83	10854-111F8	61.79	12.09	10.21
mesothelioma cell line:Mero-84	10855-111F9	43.73	3.29	12.39
mesothelioma cell line:Mero-95	10856-111G1	50.10	6.63	13.87
mesothelioma cell line:NCI-H2052	10847-111F1	63.11	12.42	14.08
mesothelioma cell line:NCI-H226	10846-111E9	35.47	3.98	10.86
mesothelioma cell line:NCI-H2452	10848-111F2	42.88	7.17	10.25
mesothelioma cell line:NCI-H28	10845-111E8	46.31	5.85	9.42
mesothelioma cell line:No36	10857-111G2	78.94	16.31	20.22
mesothelioma cell line:ONE58	10858-111G3	40.91	5.42	6.50
migratory langerhans cells, donor1	11901-125F2	32.43	3.45	9.79
migratory langerhans cells, donor2	11902-125F3	29.06	3.66	7.82
migratory langerhans cells, donor3	11903-125F4	52.23	10.05	12.56
mixed mullerian tumor cell line:HTMMT	10689-109F5	44.07	17.63	8.81
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	40.69	13.14	8.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	28.33	8.52	3.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	29.69	7.04	7.04
myelodysplastic syndrome cell line:SKM-1	10772-110F7	74.47	26.06	16.08
myeloma cell line:PCM6	10474-106I6	23.52	9.29	3.95
myxofibrosarcoma cell line:MFH-ino	10600-108E6	52.25	16.74	10.15
myxofibrosarcoma cell line:NMFH-1	10684-109E9	51.58	10.79	6.86
nasal epithelial cells, donor1, tech_rep1	12226-129F3	18.27	4.79	1.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	21.33	6.91	2.65
nasal epithelial cells, donor2	12227-129F4	19.87	3.31	4.42
neuroblastoma cell line:CHP-134	10508-107D4	54.75	11.96	8.74
neuroblastoma cell line:NB-1	10539-107G8	117.49	28.25	18.71
neuroblastoma cell line:NBsusSR	10607-108F4	34.16	9.28	5.90
neuroblastoma cell line:NH-12	10555-107I6	81.25	13.98	9.69
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	26.09	5.93	5.93
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	59.71	11.25	12.99
neuroectodermal tumor cell line:TASK1	10774-110F9	73.06	16.10	16.70
neuroepithelioma cell line:SK-N-MC	10728-110A8	54.68	13.35	8.90
neurofibroma cell line:Hs 53.T	10729-110A9	35.67	6.39	7.98
neutrophil PMN, donor1	12133-128D9	14.87	14.87	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	13.28
neutrophil PMN, donor3	12141-128E8	66.29	28.41	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	16.40	6.43	5.58
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	193.72	52.03	52.83
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	50.66	10.26	15.39
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	49.40	9.99	10.77
nucleus accumbens, adult, pool1	10037-101F1	49.59	12.56	9.56
occipital cortex - adult, donor10196	10172-103C1	76.23	16.48	20.60
occipital cortex, adult, donor10252	10163-103B1	36.77	13.15	6.71
occipital cortex, newborn, donor10223	10355-105E4	50.95	17.83	11.28
occipital lobe, adult, donor1	10076-102A4	44.61	11.55	9.71
occipital lobe, fetal, donor1	10073-102A1	48.49	10.73	10.30
occipital pole, adult, pool1	10036-101E9	41.94	9.86	8.28
olfactory region, adult	10195-103E6	47.19	14.71	9.74
optic nerve, donor1	10277-104E7	56.03	10.01	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	30.53	6.26	8.20
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	44.38	10.58	6.18
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	62.65	14.05	13.04
oral squamous cell carcinoma cell line:SAS	10544-107H4	36.39	4.85	4.62
osteoclastoma cell line:Hs 706.T	10704-109H2	37.92	6.47	10.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	110.25	17.75	26.16
osteosarcoma cell line:HS-Os-1	10558-107I9	46.44	9.75	6.57
ovary, adult, pool1	10020-101D2	29.61	5.33	5.50
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	30.98	6.97	8.25
pancreas, adult, donor1	10049-101G4	39.51	6.58	8.47
pancreatic carcinoma cell line:NOR-P1	10698-109G5	29.91	5.87	5.87
papillary adenocarcinoma cell line:8505C	10437-106E5	110.73	22.66	23.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.02	13.08	7.95
paracentral gyrus, adult, pool1	10035-101E8	48.51	13.82	11.17
parietal cortex, adult, donor10258	10373-105G4	74.87	19.08	18.35
parietal lobe - adult, donor10196	10171-103B9	48.91	13.17	12.23
parietal lobe, adult, donor10252	10157-103A4	35.06	9.98	8.84
parietal lobe, adult, pool1	10034-101E7	48.29	11.63	8.81
parietal lobe, fetal, donor1	10072-101I9	65.95	15.52	11.64
parietal lobe, newborn, donor10223	10356-105E5	50.84	25.05	12.34
parotid gland, adult	10199-103F1	41.93	6.17	8.02
penis, adult	10200-103F2	33.30	12.35	10.21
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.50	4.28	4.46
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	40.65	5.25	7.72
pineal gland - adult, donor10196	10179-103C8	52.25	19.35	6.45
pineal gland, adult, donor10252	10160-103A7	75.80	10.07	11.84
pineal gland, adult, donor10258	10377-105G8	77.13	21.95	15.68
pituitary gland - adult, donor10196	10180-103C9	50.59	24.28	9.11
pituitary gland, adult, donor10252	10162-103A9	70.88	9.90	14.07
pituitary gland, adult, donor10258	10378-105G9	97.89	27.24	17.88
placenta, adult, pool1	10021-101D3	35.05	5.05	7.20
plasma cell leukemia cell line:ARH-77	10840-111E3	38.80	11.12	9.01
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	67.86	10.74	15.25
pons, adult, pool1	10033-101E6	47.68	12.74	10.59
postcentral gyrus, adult, pool1	10032-101E5	49.17	13.95	8.80
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	4.18	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	27.54	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	140.83	58.68	0.00
prostate cancer cell line:DU145	10490-107B4	54.19	12.82	12.53
prostate cancer cell line:PC-3	10439-106E7	75.14	21.24	13.07
prostate, adult, pool1	10022-101D4	33.47	5.99	6.89
putamen, adult, donor10196	10176-103C5	72.24	24.79	13.22
putamen, adult, donor10252	10152-102I8	129.41	27.45	19.61
putamen, adult, donor10258, tech_rep1	10372-105G3	85.24	21.86	19.67
putamen, adult, donor10258, tech_rep2	10372-105G3	81.91	20.05	13.53
putamen, newborn, donor10223	10365-105F5	67.47	19.49	12.74
rectal cancer cell line:TT1TKB	10469-106I1	26.77	5.82	6.11
rectum, fetal, donor1	10067-101I4	47.29	1.39	12.52
renal cell carcinoma cell line:OS-RC-2	10411-106B6	42.61	6.78	15.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	21.54	4.56	1.24
retina, adult, pool1	10030-101E3	44.73	8.05	8.35
retinoblastoma cell line:Y79	10475-106I7	67.29	20.78	9.35
rhabdomyosarcoma cell line:KYM-1	10787-110H4	30.12	7.13	5.66
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	53.99	9.84	11.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	36.38	7.58	7.58
salivary acinar cells, donor1	11771-123I7	25.57	6.15	4.53
salivary acinar cells, donor2	11772-123I8	29.47	8.12	6.06
salivary acinar cells, donor3	11773-123I9	17.88	3.31	6.62
salivary gland, adult, pool1	10093-102C3	76.07	10.30	8.01
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	26.14	6.41	4.30
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	34.09	7.17	5.76
seminal vesicle, adult	10201-103F3	35.98	8.99	8.99
serous adenocarcinoma cell line:JHOS-2	10639-108I9	60.00	13.85	14.33
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	36.99	4.28	7.05
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	56.20	8.03	20.07
serous cystadenocarcinoma cell line:HTOA	10693-109F9	22.16	4.03	5.24
signet ring carcinoma cell line:Kato III	10436-106E4	46.42	12.71	6.96
signet ring carcinoma cell line:NUGC-4	10483-107A6	60.00	21.16	10.19
skeletal muscle - soleus muscle, donor1	10282-104F3	64.55	19.15	8.51
skeletal muscle, adult, pool1	10023-101D5	68.00	15.35	8.88
skeletal muscle, fetal, donor1	10066-101I3	25.13	4.02	6.03
skin, adult, donor1	10074-102A2	20.36	6.79	6.79
skin, fetal, donor1	10065-101I2	33.46	8.21	8.84
small cell cervical cancer cell line:HCSC-1	10800-110I8	116.73	28.35	26.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	66.82	16.71	15.45
small cell lung carcinoma cell line:DMS 144	10841-111E4	85.58	11.18	18.31
small cell lung carcinoma cell line:LK-2	10541-107H1	72.52	15.16	14.01
small cell lung carcinoma cell line:NCI-H82	10842-111E5	52.76	4.66	13.51
small cell lung carcinoma cell line:WA-hT	10562-108A4	38.35	11.55	8.72
small intestine, adult, pool1	10024-101D6	42.52	17.80	6.69
small intestine, fetal, donor1	10064-101I1	41.77	20.64	3.44
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	59.50	13.34	12.31
smooth muscle, adult, pool1	10048-101G3	34.12	4.65	6.20
somatostatinoma cell line:QGP-1	10781-110G7	20.37	7.77	3.48
spinal cord - adult, donor10196	10181-103D1	41.75	14.91	10.78
spinal cord, adult, donor10252	10159-103A6	45.34	9.07	9.07
spinal cord, adult, donor10258	10369-105F9	108.61	17.99	29.75
spinal cord, fetal, donor1	10056-101H2	56.10	20.73	19.51
spinal cord, newborn, donor10223	10359-105E8	75.77	23.42	27.09
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.17	7.62	8.36
spleen, adult, pool1	10025-101D7	25.00	5.51	3.96
spleen, fetal, pool1	10044-101F8	23.20	4.77	3.81
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	20.50	7.87	4.66
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	51.84	9.68	6.27
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	63.25	11.53	15.38
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.58	8.21	3.91
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	55.72	20.04	10.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	64.39	11.44	15.67
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	66.00	18.62	7.19
stomach, fetal, donor1	10062-101H8	52.33	12.82	8.54
submaxillary gland, adult	10202-103F4	43.30	7.41	13.10
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	53.38	12.46	9.97
substantia nigra, adult, donor10258	10371-105G2	90.00	23.79	17.59
substantia nigra, newborn, donor10223	10358-105E7	50.87	14.13	12.72
synovial sarcoma cell line:HS-SY-II	10441-106E9	71.30	22.01	13.76
temporal lobe, adult, pool1	10031-101E4	43.15	8.99	9.32
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	43.45	14.96	6.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	58.02	11.87	7.91
tenocyte, donor1	11763-123H8	52.71	8.38	14.66
tenocyte, donor2	11765-123I1	38.53	5.72	8.39
tenocyte, donor3	11768-123I4	44.11	4.82	6.67
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	65.60	23.79	10.03
teratocarcinoma cell line:NCR-G1	10798-110I6	69.98	14.18	14.80
teratocarcinoma cell line:PA-1	10807-111A6	51.45	17.05	7.28
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.96	10.41	3.68
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.53	5.67	2.65
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	25.19	6.43	4.69
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	48.53	16.29	10.42
testis, adult, pool1	10026-101D8	63.67	14.60	10.95
testis, adult, pool2	10096-102C6	99.24	25.26	20.75
thalamus - adult, donor10196	10168-103B6	58.51	19.87	8.83
thalamus, adult, donor10252	10154-103A1	50.64	10.94	8.28
thalamus, adult, donor10258, tech_rep1	10370-105G1	147.80	24.63	27.71
thalamus, adult, donor10258, tech_rep2	10370-105G1	33.76	11.53	6.59
thalamus, newborn, donor10223	10366-105F6	36.25	16.68	10.93
throat, adult	10209-103G2	44.94	9.99	5.74
throat, fetal, donor1	10061-101H7	46.01	10.36	16.76
thymic carcinoma cell line:Ty-82	10803-111A2	103.34	24.25	19.28
thymus, adult, pool1	10027-101D9	29.92	11.04	7.46
thymus, fetal, pool1	10043-101F7	25.35	6.03	4.57
thyroid carcinoma cell line:KHM-5M	10776-110G2	68.21	17.15	18.88
thyroid carcinoma cell line:TCO-1	10783-110G9	88.98	14.67	17.88
thyroid, adult, pool1	10028-101E1	59.44	8.77	12.69
thyroid, fetal, donor1	10060-101H6	49.57	8.70	13.45
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	6.16	6.16
tongue, adult	10203-103F5	60.47	16.98	9.77
tongue, fetal, donor1	10059-101H5	112.32	26.80	20.49
tonsil, adult, pool1	10047-101G2	28.25	8.11	4.71
trachea, adult, pool1	10029-101E2	33.95	5.64	5.56
trachea, fetal, donor1	10058-101H4	35.01	6.54	11.16
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	45.35	18.07	8.15
transitional-cell carcinoma cell line:5637	10418-106C4	58.05	18.74	10.03
transitional-cell carcinoma cell line:JMSU1	10492-107B6	32.28	7.05	7.68
tridermal teratoma cell line:HGRT	10694-109G1	57.08	17.12	9.51
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	36.82	4.23	6.69
umbilical cord, fetal, donor1	10057-101H3	43.82	8.35	12.52
uterus, adult, pool1	10100-102D1	43.34	5.29	8.36
uterus, fetal, donor1	10055-101H1	40.95	9.73	11.26
vagina, adult	10204-103F6	21.97	3.23	3.23
vein, adult	10191-103E2	23.45	6.80	5.04
xeroderma pigentosum b cell line:XPL 17	10563-108A5	25.90	5.07	4.01